World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
128
Citations
76889
World Ranking
378
National Ranking
228

Medicine

D-Index
129
Citations
79282
World Ranking
2547
National Ranking
1434

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Anna S.F. Lok is affiliated with the University of Michigan-Ann Arbor in the United States. Their research work primarily focuses on medicine, with significant contributions in epidemiology and hepatology, alongside studies in surgery, oncology, and cancer research.

The scientist's main topics of investigation include liver disease diagnosis and treatment, hepatitis C virus research, hepatitis B virus studies, liver disease and transplantation, hepatocellular carcinoma treatment and prognosis, hepatitis viruses studies and epidemiology, and liver diseases and immunity.

Anna S.F. Lok has published research extensively in several leading venues:

  • Hepatology (22 publications)
  • Journal of Hepatology (15 publications)
  • Gastroenterology (15 publications)
  • Clinical Gastroenterology and Hepatology (14 publications)
  • The American Journal of Gastroenterology (13 publications)

Their recent notable papers include:

  • "Hepatitis B," 2023, The Lancet
  • "How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?", 2022, Journal of Hepatology
  • "Progress towards elimination goals for viral hepatitis," 2020, Nature Reviews Gastroenterology & Hepatology
  • "International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma," 2021, Gastroenterology
  • "DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort," 2020, Journal of Hepatology

Anna S.F. Lok frequently collaborates with several researchers, including:

  • Norah A. Terrault
  • Marc G. Ghany
  • Elliot B. Tapper
  • Mandana Khalili
  • Harry L.A. Janssen

Best Publications

  • A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C

    Chun-Tao Wai;Joel K. Greenson;Robert J. Fontana;John D. Kalbfleisch

  • Chronic hepatitis B

    Anna Suk-Fong Lok;Brian J. McMahon

  • Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

    Norah A. Terrault;Anna S.F. Lok;Brian J. McMahon;Kyong Mi Chang

  • Chronic hepatitis B: Update 2009

    Anna S. F. Lok;Brian J. McMahon

  • A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B

    Ting Tsung Chang;Robert G. Gish;Robert De Man;Adrian Gadano

  • Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

    Ching Lung Lai;Daniel Shouval;Anna S. Lok;Ting Tsung Chang

  • Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

    Mark S. Sulkowski;David F. Gardiner;Maribel Rodriguez-Torres;K. Rajender Reddy

  • Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

    Anna S.F. Lok;Ching Lung Lai;Nancy Leung;Guang Bi Yao

  • Management of hepatitis B: 2000--summary of a workshop.

    Anna S. Lok;E.Jenny Heathcote;Jay H. Hoofnagle

  • Management of Hepatitis B: Summary of a Clinical Research Workshop

    Jay H. Hoofnagle;Edward Doo;T. Jake Liang;Russell Fleischer

  • EASL International Consensus Conference on Hepatitis C, Paris, 26-28 February 1999: Consensus Statement

    J. P. Benhamou;J. Rodes;H. Alter;H. Bismuth

  • Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1

    Anna S. Lok;David F. Gardiner;Eric Lawitz;Claudia Martorell

  • α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma

    Jorge A. Marrero;Ziding Feng;Yinghui Wang;Mindie H. Nguyen

  • Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

    Anna S. Lok;Leonard B. Seeff;Timothy R. Morgan;Adrian M. di Bisceglie

  • NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States

    Jorge A. Marrero;Robert J. Fontana;Grace L. Su;Hari S. Conjeevaram

  • Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort

    Jorge A. Marrero;Robert J. Fontana;Ashley Barrat;Frederick Askari

  • Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005

    Hyung Joon Yim;Anna Suk Fong Lok

  • Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.

    Anna S. Lok;Fabien Zoulim;Stephen Locarnini;Angeline Bartholomeusz

  • Chronic hepatitis B: update of recommendations.

    Anna S.F. Lok;Brian J. McMahon

  • National Institutes of Health Consensus Development Conference panel statement: Management of hepatitis C

    D. W. Powell;B. Z. Abramson;J. A. Balint;S. Belle

Frequent Co-Authors

Robert J. Fontana
Robert J. Fontana University of Michigan–Ann Arbor
Marc G. Ghany
Marc G. Ghany National Institutes of Health
William M. Lee
William M. Lee The University of Texas Southwestern Medical Center
Timothy R. Morgan
Timothy R. Morgan California State University, Long Beach
Jules L. Dienstag
Jules L. Dienstag Harvard University
Norah A. Terrault
Norah A. Terrault University of Southern California
Herbert L. Bonkovsky
Herbert L. Bonkovsky Wake Forest University
Richard K. Sterling
Richard K. Sterling Virginia Commonwealth University
Adrian M. Di Bisceglie
Adrian M. Di Bisceglie Saint Louis University
Gregory T. Everson
Gregory T. Everson University of Colorado Denver

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers goes beyond becoming a doctor. Many students consider nursing and related healthcare fields as rewarding alternatives, often accessible through flexible online study options. Selecting the right online program matters; factors like accreditation, cost, curriculum, and career outlook all play a role in your decision.

For those looking to maximize value, check out the cheapest online msn programs as well as the cheapest rn to bsn program online. These affordable pathways can prepare you for advanced nursing roles or leadership positions while managing costs.

If you already have a background in nursing and want to reach the highest academic levels, consider phd in nursing online programs that allow you to study and research while maintaining work commitments.

Even non-nurses can pivot to healthcare through specialized tracks like online msn programs for non nurses. These programs are designed for career-changers who wish to enter the field and quickly gain advanced qualifications.

Exploring your options ensures you find a program that aligns with your goals, budget, and timeline, paving the way for a rewarding career in healthcare.

Best Scientists Citing Anna S.F. Lok

Trending Scientists

Recently Published Articles